Literature DB >> 25097819

MicroRNAs in Cholangiopathies.

Steven P O'Hara1, Sergio A Gradilone1, Tetyana V Masyuk1, James H Tabibian1, Nicholas F LaRusso1.   

Abstract

Cholangiocytes, the cells lining bile ducts, comprise a small fraction of the total cellular component of the liver, yet perform the essential role of bile modification and transport of biliary and blood constituents. Cholangiopathies are a diverse group of biliary disorders with the cholangiocyte as the target cell; the etiopathogenesis of most cholangiopathies remains obscure. MicroRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression. These small RNAs may not only be involved in the etiopathogenesis of disease, but are showing promise as diagnostic and prognostic tools. In this brief review, we summarize recent work regarding the role of microRNAs in the etiopathogenesis of several cholangiopathies, and discuss their utility as prognostic and diagnostic tools.

Entities:  

Keywords:  biliary atresia; cholangiocarcinoma; cholangiocytes; microRNAs, cholangiopathies; polycystic liver disease; primary biliary cirrhosis; primary sclerosing cholangitis

Year:  2014        PMID： 25097819      PMCID： PMC4119442          DOI： 10.1007/s40139-014-0048-9

Source DB:  PubMed          Journal:  Curr Pathobiol Rep        ISSN： 2167-485X


  85 in total

Review 1.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

2.  Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Authors:  K M Boberg; A Bergquist; S Mitchell; A Pares; F Rosina; U Broomé; R Chapman; O Fausa; T Egeland; G Rocca; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

3.  Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.

Authors:  Ellian Wang; Hsiu-Mei Hsieh-Li; Yuan-Yow Chiou; Yi-Lin Chien; Hua-Hui Ho; Hsian-Jean Chin; Chi-Kuang Leo Wang; San-Chi Liang; Si-Tse Jiang
Journal:  J Pathol       Date:  2010-11       Impact factor: 7.996

Review 4.  Systematic review: the pathophysiology and management of polycystic liver disease.

Authors:  F Temmerman; L Missiaen; B Bammens; W Laleman; D Cassiman; C Verslype; J van Pelt; F Nevens
Journal:  Aliment Pharmacol Ther       Date:  2011-07-26       Impact factor: 8.171

Review 5.  Ludwig symposium on biliary disorders--part I. Pathogenesis of ductal plate abnormalities.

Authors:  V J Desmet
Journal:  Mayo Clin Proc       Date:  1998-01       Impact factor: 7.616

6.  The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.

Authors:  Lei Chen; He-Xin Yan; Wen Yang; Liang Hu; Le-Xin Yu; Qiong Liu; Liang Li; Dan-Dan Huang; Jin Ding; Feng Shen; Wei-Ping Zhou; Meng-Chao Wu; Hong-Yang Wang
Journal:  J Hepatol       Date:  2008-11-21       Impact factor: 25.083

7.  Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.

Authors:  Thomas Decaens; Cécile Godard; Aurélien de Reyniès; David S Rickman; François Tronche; Jean-Pierre Couty; Christine Perret; Sabine Colnot
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

8.  MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.

Authors:  Seung-Ok Lee; Tatyana Masyuk; Patrick Splinter; Jesús M Banales; Anatoliy Masyuk; Angela Stroope; Nicholas Larusso
Journal:  J Clin Invest       Date:  2008-10-23       Impact factor: 14.808

Review 9.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

10.  miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.

Authors:  Kinya Okamoto; Kenichi Miyoshi; Yoshikazu Murawaki
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240
View more
  13 in total

Review 1.  Advanced endoscopic imaging of indeterminate biliary strictures.

Authors:  James H Tabibian; Kavel H Visrodia; Michael J Levy; Christopher J Gostout
Journal:  World J Gastrointest Endosc       Date:  2015-12-10

Review 2.  Endoscopic management of benign biliary strictures.

Authors:  Kavel H Visrodia; James H Tabibian; Todd H Baron
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

3.  Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.

Authors:  Indsey Kennedy; Heather Francis; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Liver Res       Date:  2017-04-26

4.  MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.

Authors:  Adrian P Mansini; Maria J Lorenzo Pisarello; Kristen M Thelen; Maetzin Cruz-Reyes; Estanislao Peixoto; Sujeong Jin; Brynn N Howard; Christy E Trussoni; Gabriella B Gajdos; Nicholas F LaRusso; Maria J Perugorria; Jesus M Banales; Sergio A Gradilone
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

Review 5.  Pathobiology of biliary epithelia.

Authors:  Angela C Cheung; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-15       Impact factor: 5.187

Review 6.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

7.  Hyperosmotic stress activates the expression of members of the miR-15/107 family and induces downregulation of anti-apoptotic genes in rat liver.

Authors:  David Santosa; Mirco Castoldi; Martha Paluschinski; Annika Sommerfeld; Dieter Häussinger
Journal:  Sci Rep       Date:  2015-07-21       Impact factor: 4.379

8.  A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.

Authors:  Jordan Plieskatt; Gabriel Rinaldi; Yanjun Feng; Jin Peng; Samantha Easley; Xinying Jia; Jeremy Potriquet; Chawalit Pairojkul; Vajarabhongsa Bhudhisawasdi; Banchob Sripa; Paul J Brindley; Jeffrey Bethony; Jason Mulvenna
Journal:  BMC Cancer       Date:  2015-04-23       Impact factor: 4.430

9.  Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.

Authors:  Sven H Loosen; Georg Lurje; Georg Wiltberger; Mihael Vucur; Alexander Koch; Jakob N Kather; Pia Paffenholz; Frank Tacke; Florian T Ulmer; Christian Trautwein; Tom Luedde; Ulf P Neumann; Christoph Roderburg
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

Review 10.  The changing faces of cholangitis.

Authors:  Sum P Lee; Joseph R Roberts; Rahul Kuver
Journal:  F1000Res       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.